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Abstract Creating novel biosynthetic pathways andmodulat-
ing the synthesis of important compounds are one of the hall-
marks of synthetic biology. Understanding the key parameters
controlling the flux of chemicals throughout a metabolic path-
way is one of the challenges ahead. Isoprenoids are the most
functionally and structurally diverse group of natural products
from which numerous medicines and relevant fine chemicals
are derived. The well-characterized and broadly used produc-
tion organism Bacillus subtilis forms an ideal background for
creating and studying novel synthetic routes. In comparison to
other bacteria, B. subtilis emits the volatile compound iso-
prene, the smallest representative of isoprenoids, in high
concentrations and thus represents an interesting starting
point for an isoprenoid cell factory. In this study, the effect
of systematic overexpression of the genes involved in the
methylerythritol phosphate (MEP) pathway on isoprenoid
production in B. subtilis was investigated. B. subtilis strains
harboring a plasmid containing C30 carotenoid synthetic
genes, crtM and crtN, were combined with pHCMC04G
plasmids carrying various synthetic operons of the MEP
pathway genes. The levels of produced carotenoids,
diaponeurosporene and diapolycopene, were used as
indication of the role of the various enzymes on the flux
of the MEP pathway. It was shown that the production of
carotenoids can be increased significantly by overexpress-
ing the MEP pathway enzymes. More broadly, the strains
developed in this study can be used as a starting point for
various isoprenoid cell factories.
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Introduction
Isoprenoids, also known as terpenoids, represent the most
functionally and structurally diverse group of natural prod-
ucts. They are found widespread among living organisms.
Numerous isoprenoids have attracted commercial interest as
pharmaceuticals or nutraceuticals. For example, isoprenoids
extracted from plants are used as anticancer (paclitaxel) and
antimalarial (artemisinin) drugs, whereas volatile monoter-
penes are used as flavors and fragrances (Wallaart et al.
1999). Most isoprenoids are naturally produced in small quan-
tities, and purification from biological material suffers from
low yields, impurities, and consumption of large amounts of
natural resources. Moreover, chemical synthesis of the major-
ity of isoprenoids is problematic and expensive due to the
complexity of their molecules. Therefore, the need for alter-
native methods of production for important isoprenoids has
been a pressing issue in the last few decades, and to face this
challenge, researchers extensively explored microbial produc-
tion of isoprenoids (Martin et al. 2003).
Despite the great diversity of their structures, all
isoprenoids are synthesized by consecutive condensation of
two five-carbon precursors, isopentenyl diphosphate (IPP)
Electronic supplementary material The online version of this article
(doi:10.1007/s00253-015-6531-3) contains supplementary material,
which is available to authorized users.
* Wim J. Quax
w.j.quax@rug.nl
1 Department of Pharmaceutical Biology, GRIP, University of
Groningen, Antonius Deusinglaan 1, 9713
AV Groningen, The Netherlands
Appl Microbiol Biotechnol (2015) 99:5907–5915
DOI 10.1007/s00253-015-6531-3
and its isomer dimethylallyl diphosphate (DMAPP) (Julsing
et al. 2006). For decades, the mevalonate (MVA) pathway was
assumed to be the only source for IPP/DMAPP in all living
organisms. However, it has been established nowadays that
the MVA pathway is present in eukaryotes (the cytosol and
mitochondria of plants), in archaea, and in some eubacteria
(Bloch 1992; Smit and Mushegian 2000; Wilding et al. 2000).
An alternative pathway for IPP/DMAPP formation, the 2-C-
methyl-D-erythritol-4-phosphate (MEP) or 1-deoxy-D-
xylulose-5-phosphate (DOXP) pathway (Fig. 1), was discov-
ered recently to occur in eubacteria, algae, cyanobacteria, and
the chloroplasts of plants (Eisenreich et al. 2004; Hunter 2007;
Lichtenthaler 2000; Rohmer 1999).
There are many differences between the MVA and MEP
pathways regarding stoichiometry, energy consumption, and
the equilibrium between oxidation and reduction of glucose to
IPP/DMAPP conversion (Steinbüchel 2003). The MVA path-
way involves seven enzymes and starts by formation of
acetoacetyl-CoA from two molecules of acetyl-CoA proceed-
ing until the production of IPP/DMAPP. The MVA pathway
has been extensively studied and introduced into heterologous
hosts including Escherichia coli (Anthony et al. 2009; Martin
et al. 2003; Rohdich et al. 2001). On the other hand, the MEP
pathway utilizes pyruvate and glyceraldehyde-3-phosphate as
starting materials. For E. coli, the complete MEP pathway has
been elucidated, all genes involved have been determined, and
their corresponding enzymes were described (Eisenreich et al.
2004). The story is different for B. subtilis where only a few
studies have explored the MEP pathway leaving many ques-
tions yet to be answered (Julsing et al. 2007; Wagner et al.
2000; Xue and Ahring 2011).
B. subtilis contains an endogenous MEP pathway produc-
ing levels of isoprene higher than most other eubacteria in-
cluding E. coli (Kuzma et al. 1995). B. subtilis has a broad
metabolic potential, high growth rate, and wide substrate
range. In addition, B. subtilis is listed by the Food and Drug
Administration as generally regarded as safe (GRAS). These
properties make B. subtilis an excellent candidate for the pro-
duction of food grade or pharmaceutical isoprenoids by en-
hancing the flux of isoprenoid precursors via the MEP path-
way. Some information regarding the improvement of the
MEP pathway in B. subtilis has been reported (Julsing et al.
2007; Xue and Ahring 2011). The production of isoprenoids
in B. subtilis has been limitedly studied where Yoshida et al.
(2009) report the production of C30 carotenoids by expression
of CrtM and CrtN genes. Also, overexpression of dxs and idi
Fig. 1 MEP pathway in B. subtilis. Eight enzymes are involved in the
conversion of D-glyceraldehyde-3-phosphate and pyruvate to IPP and
DMAPP. These two products are precursors for isoprenoid compounds
such as carotenoids. Enzymes in the metabolic pathway: 1-deoxy-D-
xylulose-5-phosphate synthase (Dxs), 1-deoxy-D-xylulose-5-phosphate
reductoisomerase or 2-C-methyl-D-erythritol 4-phosphate synthase (Dxr,
IspC), 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (IspD),
4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol kinase (IspE), 2-C-
methyl-D-erythritol 2,4-cyclodiphosphate synthase (IspF), (E)-4-
hydroxy-3-methylbut-2-enyl-diphosphate synthase (IspG), 4-hydroxy-3-
methylbut-2-enyl diphosphate reductase (IspH), and isopentenyl-
diphosphate delta-isomerase (Idi). Intermediates in the metabolic
pathway: 1-deoxy-D-xylulose 5-phosphate (DXP), 2-C-methyl-D-
erythritol 4-phosphate (MEP), 4-(cytidine 5′-diphospho)-2-C-methyl-D-
erythritol (CDP-ME), 2-phospho-4-(cytidine 5′-diphospho)-2-C-methyl-
D-erythritol (CDP-MEP), 2-C-methyl-D-erythritol 2,4-cyclodiphosphate
(MEC), (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate (HMBPP),
isopentenyl diphosphate (IPP), and dimethylallyl diphosphate (DMAPP)
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was shown to increase production of the C15 terpenoid
amorphadiene in B. subtilis (Zhou et al. 2013). We chose to
explore the engineering of endogenous MEP pathway in
B. subtilis rather than the heterologous MVA pathway, as
using endogenous genes requires less genetic adaptations
and has a higher chance of producing correctly folded proteins
and, hence, success. In the current study, we aim at examining
the effect of MEP pathway modulation on the production of
isoprenoids in B. subtilis. Until now, only the effect of over-
expression of dxs, ispC, and idi genes (in B. subtilis MEP
pathway) on the overall production of isoprenoids has been
reported, while the other enzymes in the pathway have yet to
be explored. We describe the systematic analysis of a series of
synthetic operons expressing most of the respective enzymes
from the B. subtilisMEP pathway. The level of production of
C30 carotenoids was used as a read out to assess the effect of
such modulations. This study can provide a basis for further
fine tuning of theMEP pathway in B. subtilis aiming at a more
efficient production of isoprenoids.
Materials and methods
Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. Experiments with E. coliDH5α strains were performed
using Luria-Bertani broth (LB) while those with B. subtilis 168
strains were performed using tryptic soy broth (TSB) (17 g/l
tryptone, 3 g/l soytone, 2.5 g/l dextrose, 5.0 g/l NaCl, 2.5 g/l
K2HPO4). Both E. coli and B. subtilis 168 were grown at 37 °C
under shaking conditions. When necessary, growth media were
supplemented with antibiotics in the following concentrations:
10 μg/ml chloramphenicol, 100 μg/ml ampicillin, or 100 μg/ml
erythromycin forE. coliDH5α and 5μg/ml chloramphenicol or
20 μg/ml tetracycline for B. subtilis 168.
Construction of MEP pathway synthetic operons
The synthetic operons were constructed partly based on the
procedure as described by Akhtar and Jones (2008). Primers
to amplify the genes are listed in Table S1.
Eight synthetic operons, each containing from one to four
genes of the MEP pathway, were constructed. The first gene
(dxs) was amplified using a forward primer that contains a
SpeI restriction site and the B. subtilis mntA ribosomal binding
site (RBS) plus linker (AAGAGGAGGAGAAAT) and a re-
verse primer that contains a linker with SwaI and BglII restric-
tion sites, a 6× His-tag, a stop codon, and a BamHI restriction
site (Fig. S1). The amplified product was cloned into the
pHB201 plasmid via SpeI and BamHI sites. The consecutive
genes were cloned as follows: The next gene to be introduced
was amplified with a forward primer containing a StuI restric-
tion site, a stop codon for the previous gene, and the B. subtilis
mntARBS plus linker, and a reverse primer containing a linker
with SwaI and BglII restriction sites. The amplified gene was
then cut at the StuI and BglII restriction sites and cloned into
the pHB201-dxs constructed plasmid cut with SwaI and BglII
restriction enzymes. This procedure was repeated until up to
four genes were cloned into the pHB201 plasmid. Based on
the gene sequences, a silent mutation was performed whenev-
er necessary or a restriction site for SmaI was used instead of
StuI.
The synthetic operons were cut from the pHB201 plasmid
with restriction enzymes SpeI and BamHI (see Fig. S1) and
introduced into the SpeI/BamHI-restricted pHCMC04G plas-
mid constructed in this study (see supplementary material and
Fig. S2). The pHCMC04G plasmid has a θ-replication sys-
tem, making it more stable than the pHB201 plasmid; hence, it
will be used for expression in B. subtilis 168. The resulting
constructs are listed in Table 2, and the sequences of all the
plasmids were confirmed by sequencing (Macrogen, Europe).
The pHCMC04G constructs were chosen to transform
Table 1 Bacterial strains and
plasmids used in this study Bacterial strain Genotype Reference
B. subtilis 168 trpC2 Kunst et al. (1997); Barbe
et al. (2009)
E. coli DH5α F−endA1 hsdR17 (rk
−,mk
+) supE44 thi−
1 λ−recA1 gyrA96 relA1 φ80dlacZΔM15
Bethesda Research
Laboratories 1986
Plasmid Relevant properties Reference
pHB201 B. subtilis and E. coli shuttle vector;
ori-pUC19; ori-pTA1060; P59
promoter; cat86::lacZα; CmR; EmR
Bron et al. (1998)





pHYCrtMN B. subtilis and E. coli shuttle vector;
ori-pACYC177; ori-pAMα1; crtM and
crtN genes of S. aureus; AmpR; TcR
Yoshida et al. (2009)
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competent B. subtilis 168 cells as described by Kunst and
Rapoport (1995).
Expression of MEP pathway genes
To check for the production of MEP pathway enzymes,
B. subtilis 168 strains with pHCMC04G constructs were
grown in 50 ml TSB medium containing appropriate antibi-
otics. Overnight cultures were diluted to an optical density at
600 nm (OD600) of 0.05 in TSB medium. The cultures were
grown for 3 h at 37 °C under shaking conditions (250 rpm).
Then, xylose was added to a final concentration of 1 % to start
induction. The cultures were grown overnight before protein
expression analysis was done. Cells were collected by centri-
fugation, 30min at 2100g, 4 °C, and resuspended in 2 ml lysis
buffer (25 mMTris-HCl, pH 8.0, 25 mMNaCl, 20% glucose,
and 0.25 mg/ml lysozyme). Cells were lysed by incubation at
37 °C for 30 min, and the soluble protein fractions were col-
lected by centrifugation, 20 min at 17,000g. Proteins were
then purified using HisSpinTrap™ columns (GE Healthcare)
using 25mMTris-HCl, 500 mMNaCl, and 20mM imidazole,
pH 7.4, as equilibration and wash buffer and 25mMTris-HCl,
500 mM NaCl, and 500 mM imidazole, pH 7.4, as elution
buffer and were analyzed by SDS-PAGE using precast
NuPAGE® gels (Invitrogen) and Western blotting. For
Western blotting, the presence of His-tagged proteins was
monitored by immunodetection with specific antibodies
against the His-tag. Primary bound antibodies were visualized
using fluorescent IgG secondary antibodies (IRDye800 CW
goat anti-rabbit LiCor Biosciences). Membranes were
scanned for fluorescence at 800 nm using the Odyssey
Infrared Imaging System (LiCor Biosciences).
Introduction of pHYcrtMN in B. subtilis 168 cells
overexpressing MEP pathway genes
B. subtilis 168 cells containing the pHCMC04G plasmidswith
the synthetic operons were transformed with the pHYcrtMN
plasmid (Yoshida et al. 2009) as described before by Kunst
and Rapoport (1995) and plated on LB agar plates containing
chloramphenicol and tetracycline. Yellow colonies were
picked for extraction and analysis of the produced
carotenoids.
Extraction of carotenoids from B. subtilis 168
Carotenoids were extracted from B. subtilis 168 cells as de-
scribed before by Yoshida et al. (2009) with a few modifica-
tions. Overnight cultures of B. subtilis 168 strains containing
pHYcrtMN and pHCMC04G with synthetic MEP operons
were inoculated in 50 ml TSB at OD600 0.05. Then, 1 %
xylose was added for induction after 3 h and the strains were
cultured for a total of 24 h at 37 °C (250 rpm). Samples were
then centrifuged at 2100g for 30min, and pellets were washed
with 1 ml TE (10 mM Tris, 1 mM EDTA). The cells were
resuspended in 200 μl TE, and 20 μl squalene (0.97 mg/ml,
dissolved in isopropanol) was added as an internal standard.
To extract the carotenoids, cells were lysed by adding 50 μl of
20 mg/ml lysozyme and incubating for 15 min at 37 °C. Cell
lysates were then transferred into glass tubes, covered in alu-
minum foil to avoid light exposure, and centrifuged for 20min
at 2100g. After discarding the supernatant, 1 ml acetone was
added to the pellets and they were vortexed for 2 min. The
samples were incubated at 55 °C for 1 min then vortexed for
1 min, followed by centrifugation for 10 min at 2100g. The
supernatants were transferred to new glass tubes. The acetone
extraction was repeated four times. Then, the acetone extracts
were evaporated and the remaining carotenoids were dis-
solved in 100 μl acetone and collected in HPLC vials. The
extracts were used for HPLC analysis. All strains were cul-
tured in triplicates under the same conditions, and the extrac-
tion of each sample was performed in parallel. Cell dry weight
was determined by pelleting and drying a fraction of the
culture.
Carotenoid isolation and identification
Isolation of the carotenoids was carried out by preparative
HPLC (Millipore) using a C18 column (Phenomenex Luna
5 μm, 100 Å, 250×21.20 mm). Acetone extracts were loaded
on the column and eluted by acetonitrile and H2O (92:8 %) at
a flow rate of 8 ml/min. The carotenoids were eluted at 38 and
41 min and then identified by UV spectrum and liquid
chromatography/mass spectrometry (LC/MS) analysis.
Purified carotenoids were used as standard compounds for
quantitative analysis.
HPLC analysis of carotenoids from B. subtilis 168
All samples were analyzed with Shimadzu HPLC system
equipped with a Kinetex C18 column (2.6 μm, 100 Å, 100×
4.60 mm) at 25 °C with a diode array detector. Carotenoids
were eluted with acetonitrile/water at 1 ml/min. Mobile phase
Table 2 Plasmid constructs used for expression in B. subtilis
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A consists of 5 % acetonitrile, 95 % H2O, and 0.1 %
trifluoroacetic acid (TFA). Mobile phase B consists of
100 % acetonitrile and 0.1 % TFA. The HPLC program was
as follows: 0–15 min, 92 % mobile phase B; 16–30 min,
100 % mobile phase B; and 31–35 min, 92 % mobile phase
B to equilibrate the column for next run. Injection volume was
20 μl, and detection was carried out at 450 nm for carotenoids
and 200 nm for squalene. The results were calibrated by the
internal standard squalene, and the carotenoids produced by
all strains were quantified using carotenoid standard curves.
The B. subtilis strain that only contains the pHYcrtMN plas-
mid was used as a control strain.
Nucleotide sequence accession number
The nucleotide sequence of the complete genome of Bacillus
subtilis 168 was awarded the following accession numbers:
AL009126 and NC000964. All genes used in this study were
amplified from the genomic DNA of this strain.
Results
A synthetic operon for coordinated expression of MEP
pathway genes can be stably maintained in B. subtilis 168
To investigate the possible increase of the intracellular con-
centration of isoprenoids, we assembled the endogenous
genes of B. subtilis 168 encoding the MEP pathway in a syn-
thetic operon that is expressed from a plasmid. We divided the
genes in two groups, referred to as BA^ and BB^ from here on
(Fig. 2). The division is based on the results obtained from
previous research in our lab (Julsing et al. 2007), where the
effect of the MEP pathway genes on isoprene production was
studied using B. subtilis 168 single conditional mutants. In
that study, the dxs, ispD, ispF, and ispH mutants showed, at
minimal required induction for survival, the largest decrease
in isoprene production and might therefore represent the cat-
alysts with the largest control on the flux in the pathway lead-
ing to isoprenoid production. Similarly, Yuan and colleagues
found in E. coli that when dxs, ispD, and ispF were
overexpressed by using a strong bacteriophage promoter, the
production of β-carotene was increased in these strains (Yuan
et al. 2006). Thus, the dxs, ispD, ispF, and ispH genes repre-
sent group A. Group B contains the other three genes of the
MEP pathway—ispC, ispE, and ispG—and the downstream
gene ispA(yqiD) that codes for a farnesyl diphosphate syn-
thase. The latter enzyme catalyzes the formation of geranyl
diphosphate (GPP) and farnesyl diphosphate (FPP) leading to
geranylgeranyl diphosphate (GGPP) from the precursors IPP/
DMAPP. The idi gene (the final gene in the MEP pathway
encoding for an IPP isomerase) was not chosen in construc-
tion of the operons based on indications that it is non-essential
in B. subtilis (Takagi et al. 2004). Previous research also
showed that a knockout B. subtilis strain of the ypgA gene
encoding idi is viable and produces isoprene. The isoprene
production implies that the synthesis of the isomer DMAPP
does not rely on the isomerase (Eisenreich et al. 2004; Julsing
et al. 2007). Synthetic operons were constructed by first clon-
ing into pHB201 then transferring to pHCMC04G resulting in
eight different pHCMC04G constructs. The constructs were
initially assembled in E. coli and subsequently transferred to
B. subtilis 168 where they were found to be stably maintained.
All MEP pathway enzymes can be overexpressed
in B. subtilis 168
In order to monitor expression of the consecutiveMEP pathway
genes, cell lysates were enriched for His-tagged proteins and
analyzed byWestern blotting. In our design, only the last protein
carries a His-tag. As all genes on the plasmid are in one operon
and were checked by sequencing, it can be concluded that the
transcripts are intact whenever this last protein is visible. This
strategywas preferred over one where all proteins contain a His-
tag, as addition of any sequence, and thus, also a His-tag may
have an influence on the folding and/or activity of a protein. All
enzymes from theMEP pathway can be detected on theWestern
blot proving that they are overexpressed in B. subtilis 168.
Carotenoid production is highly increased in MEP
pathway-engineered B. subtilis 168 strains
A comparison of carotenoid production in the different strains
of modified B. subtiliswas performed where carotenoids were
quantified by HPLC. The B. subtilis strain that only contains
the pHYcrtMN plasmid was used as a control strain. The
chromatograms show two major peaks at 450 nm (Fig. S3).
The first peak, with maximal absorbance at 443, 472, and
501 nm, eluted at 8.5 min. The mass spectra of this peak
showed [M+H]+ at m/z 401, which is in agreement with the
molecular formula C30H40 of 4,4′-diapolycopene (Figs. S3
and S4a). The second peak eluting at 10.5 min was identical
to that of 4,4′-diaponeurosporene as its absorption maxima
were at 415, 439, and 469 nm, and the mass spectra showed
[M+H]+ at m/z 403 which is in accord with the formula
C30H42 (Figs. S3 and S4b) (Takaichi 2000; Takaichi et al.
1997). Squalene was detected at 200 nm and eluted from the
column at 24.5 min. The biosynthetic pathway involves con-
version of 4,4′-diaponeurosporene to 4,4′-diapolycopene in a
reaction catalyzed by CrtN (Wieland et al. 1994). Literature
shows that CrtN has far less activity than CrtM in
Staphylococcus aureus. Wild-type S. aureus does not produce
any 4,4 ′-diapolycopene, and in mutants where the
downstream pathway from 4,4′-diaponeurosporene to
staphyloxanthin was blocked, only a small amount of 4,4′-
diapolycopene was produced (Marshall and Wilmoth 1981a;
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Marshall and Wilmoth 1981b). It is apparent that this is also
the case in B. subtilis 168 since peaks for both 4,4′-
diaponeurosporene and 4,4′-diapolycopene were present in
the chromatograms of all samples. Thus, the two compounds
were calculated individually and together as total carotenoids.
The results are shown in Fig. 3 and Table 3. The sum of the
two carotenoids was quite constant between replicates as ev-
idenced by the low standard deviations.
B. subtilis strain p04S which carries dxs shows a total ca-
rotenoid level of 4.81 (±0.114) mg/g dry cell weight (dcw),
which is an 8-fold increase in total carotenoid production com-
pared to the control strain (Fig. 3 and Table 3). In strain p04SD
overexpressing dxs and ispD, production of carotenoids was
increased by 8.7-fold compared to the control strain. The level
of carotenoid production is slightly increased compared to
strain p04S, suggesting that ispD has a low contribution to
the overall flux of the MEP pathway, thus not considered a
bottleneck in production of isoprenoids. Additional overex-
pression of ispF together with dxs and ispD in strain p04SDF
resulted in an 11.4 times elevation in carotenoid production
compared to the control strain. This implies that ispF is










Fig. 3 Quantitative analyses of carotenoids produced in B. subtilis 168
strains overexpressing MEP pathway enzymes. Carotenoids were
extracted from B. subtilis 168 cells with acetone. Samples were
analyzed by HPLC. Individual and total amount of carotenoids were
calibrated by the internal standard squalene and determined using
carotenoid standard curves. Shown are the amounts of produced
carotenoids in strains overexpressing MEP pathway enzymes from the
pHCMC04G plasmid per gram dry cell weight (±standard deviation). The
amount of diaponeurosporene is indicated in black and the amount of
diapolycopene in gray. The experiments were performed in triplicate
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important for an increase in the pathway flux. Finally, in strain
p04SDFH expressing all group A genes, the yield of carotenoids
was increased by 15-fold relative to the control strain.
Regarding the strains with group B operon, carotenoid pro-
duction from strain p04C harboring ispC(dxr) was 9.2-fold
higher compared to the control strain. This shows for the first
time the importance of overexpressing ispC, which was not
reported in previous studies. The level of isoprene production
was previously reported to be not significantly changed in the
B. subtilis strain overproducing ispC (Xue and Ahring 2011).
In strains p04CE and p04CEG, carotenoid production concur-
rently showed a 12.7-fold and 13.1-fold increase compared to
the control strain. The highest total amount of carotenoids was
obtained with the strain that overexpressed all group B genes:
ispC, ispE, ispG, and ispA (strain p04CEGA). Additional
overexpression of ispA in strain p04CEGA improved the pro-
duction of total carotenoids by 17.8-fold (10.65 mg/g dcw)
compared to the control strain.
Discussion
Research in recent years has been directed toward eluci-
dating the pathways leading to IPP and DMAPP, the
building blocks in the biosynthesis of numerous natural
products. Most studies have focused on the MVA path-
way and on improving the flux through it both in natural
hosts as in heterologous hosts. Recently, the attention has
been shifted toward the MEP pathway endogenous to
many eubacteria.
In this work, we have focused on the systematic analysis of
the consecutive enzymes constituting the MEP pathway in
B. subtilis. In a follow-up to our previous systematic deletion
study of genes encodingMEP pathway enzymes (Julsing et al.
2007), we now have constructed synthetic operons encoding
combinations of genes for overexpression of MEP pathway
enzymes. As it had already been shown that the endogenous
MEP pathway can be used for carotenoid production in
B. subtilis 168 (Yoshida et al. 2009), we decided to use a
C30 carotenoid-producing plasmid as a quantitative readout
system for measuring the flux to isoprenoid production.
From our studies, it is clear that an increase in the formation
of carotenoids occurs when the level of isoprenoid precursors
in B. subtilis 168 cells is elevated by engineering the MEP
pathway. In order to unravel the individual contribution of
each of the enzymes, B. subtilis 168 strains where transformed
with synthetic operons harboring stepwise augmented combi-
nations of the MEP pathway enzymes encoding genes on a
plasmid. The vector used for gene expression was the
pHCMC04G plasmid with a θ-replication system, in which
expression is controlled by the xylose-inducible PxylA promot-
er. As can be seen from Fig. 3, each insertion of an additional
gene from group A or from group B leads to a higher produc-
tion of carotenoids. This implies that almost each of the en-
zymes has, to varying extents, a control on the flux through
the MEP pathway.
Overexpression of dxs showed a high increase in caroten-
oid yield (8-fold). This is in agreement with previous findings
that overexpression of dxs results in higher amounts of
isoprenoids in B. subtilis 168 (Xue and Ahring 2011;
Zhou et al. 2013), although the extent of the increase in
our study is much higher. Also, the strain overexpressing
ispC(dxr) from plasmid p04C shows a 9.2-fold increase
in carotenoid production. Previous studies in B. subtilis
suggested that the amount of DXR is not a limiting step
for isoprenoid biosynthesis (Xue and Ahring 2011).
However, it has been reported in E. coli that the effect
of ispC overexpression on MEP pathway flux can vary
(Kim and Keasling 2001).
Each consecutive expression of an additional enzyme in-
volved in the MEP pathway resulted in a higher amount of
carotenoids detected. In group A synthetic operons, the limit-
ed increase in strain p04SD indicates that ispD is not a rate
limiting step in the MEP pathway, at least not at the current
production levels. For the same reason, as additional expres-
sion of ispF increased the level of produced carotenoids sig-
nificantly, it is suggested that ispF has a larger contribution to
the flux control in the MEP pathway than ispD. Additional
insertion of gene ispH (p04SDFH) yields 9.03 (±0.16) mg/g
dcw carotenoids, which is 30 % higher compared to strain
p04SDF and a 15-fold increase over the control strain, dem-
onstrating that the flux of isoprenoids can be further improved
by enhancing ispH expression. The highest amount of pro-
duced carotenoids was observed in the strain overexpressing
all group B enzymes (p04CEGA), which produces
10.65 (±0.13) mg/g dcw carotenoids representing ~18-fold
Table 3 Amount of carotenoids produced by engineered B. subtilis
strains and relative increase compared to control strain










a The total amount of carotenoids was measured in triplicate (±standard
deviation)
b The relative increase is calculated as the amount of carotenoids pro-
duced in the engineered B. subtilis strain divided by the amount of carot-
enoids produced in the B. subtilis strain containing only the carotenoids
producing plasmid pHYCrtMN
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increase over wild-type B. subtilis. This large increase is main-
ly caused by the major influence of ispC on the caroten-
oid production that was not anticipated based on previ-
ous reports. It is possible that the B. subtilis 168 strain
used by Xue and Ahring (2011) exhibits a higher en-
dogenous ispC expression level than the one used by
us; hence, their overexpression of ispC has limited im-
pact on isoprene production. Within the framework of
the Bacillus functional analysis project, it has been not-
ed that even after limited passages, the B. subtilis 168-
type strain does acquire multiple mutations that can al-
ter the phenotype considerably (Barbe et al. 2009).
Our findings concerning the level of increase in carot-
enoid production were compared with the level of de-
crease in isoprene production observed in the previous
knockout study in B. subtilis (Julsing et al. 2007).
Interestingly, strains overexpressing ispC, ispE, ispF,
and ispH showed the expected effect on formation of
the final products, to an extent that is in accord with the
corresponding knockout strains. Dxs has a significant in-
fluence on the end products of both dxs knockout strain
and overexpression strain (p04S), so this further confirms
the key role of dxs in the MEP pathway. In the ispD
knockout strain, a large decrease in isoprene production
was observed. However, the amount of carotenoids pro-
duced in the strain additionally overexpressing ispD
(p04SD) was only 1.1-fold higher than that in strain
p04S. This may be indicative of the fact that ispD is
essential for isoprenoid production, but its contribution
to the flux control is low. Also, the increase in carotenoid
production with overexpression of the rest of the MEP
pathway enzymes is in concert with the effect of the cor-
responding knockout strains.
In conclusion, the observed enhancement of carotenoid
production in the engineered B. subtilis 168 indicates that
MEP pathway modulation shows a great promise for the pro-
duction of isoprenoids. The engineered B. subtilis 168 strains
provided by this study in combination with other terpene
synthases represent an opportunity for a GRAS cell factory
for the production of numerous isoprenoids.
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